Autopsy report · NCT03623464
RCT of Mobile Apps & FitBit v. Usual Care
Cause of deathOther
“Study is paused for interim analysis.”
Life of this trial
- Registered 1 month before it started.
- Suspended: paused, and may or may not restart.
- 107 participants enrolled.
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University, hospital or other
- Conditions
- Pancreatic Cancer; Gastric Cancer; Hepatic Cancer; Colon Cancer; Rectal Cancer; Small Bowel Cancer
- Interventions
- Mobile health application and Fitbit + standard of care; Standard of care
- Participants
- 107
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics
“study paused for interim analysis” - A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
“Study was stopped following interim analysis.” - A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma
“results from interim analysis conducted to study interruption” - Moxonidine in Patients Undergoing Vascular Surgery
“Study was stopped after pre-definied interim analysis because of no effects” - Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation
“Study was stopped after interim analysis and slow enrollment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.